Validation of Immunohistochemistry for the Detection of <i>BRAF</i> V600E-Mutated Lung Adenocarcinomas
<i>BRAF</i> V600E mutation, a missense mutation in exon 15 resulting in valine substitution for glutamate at position 600 within the kinase domain of BRAF oncogene, is found in a subset of lung adenocarcinoma (ADC). The usefulness of immunohistochemistry (IHC) as an alternative diagnosti...
Main Authors: | Chien-Hung Gow, Min-Shu Hsieh, Yen-Ting Lin, Yi-Nan Liu, Jin-Yuan Shih |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/6/866 |
Similar Items
-
Survival outcomes and prognostic factors of lung cancer patients with the MET exon 14 skipping mutation: A single-center real-world study
by: Chien-Hung Gow, et al.
Published: (2023-03-01) -
VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting <i>BRAF</i><sup>V600E</sup> Mutation in Papillary Thyroid Cancer
by: Sonam Choden, et al.
Published: (2020-03-01) -
Result Analysis of BRAF V600E Gene Mutation Using Molecular and Immunohistochemistry Detection in Acral Malignant Melanoma
by: Hermin Aminah Usman, et al.
Published: (2018-09-01) -
Five cases of BRAF V600E-mutant lung adenocarcinoma with high expression of programmed death ligand 1
by: Takuma Katano, et al.
Published: (2020-01-01) -
Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
by: Chien-Hung Gow, et al.
Published: (2021-08-01)